ArticleBMC urology2025
Factors predicting ureteral stenosis after transurethral resection of the ureteral orifice: a two-center, retrospective clinical study.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe aimed to evaluate the factors predictive of ureteral stenosis after orifice resection and to determine whether ureteral stenting is effective in preventing it.
methodsThe data of patients who underwent transurethral resection of bladder tumor (TUR-BT) in the clinics of two tertiary centers between June 2020 and January 2024 were retrospectively reviewed. Patients who underwent orifice resection due to tumor involvement of the ureteral orifice or too close to it were included in the study. During follow-up, cystoscopy ± diagnostic ureterorenoscopy was performed in patients with hydronephrosis. Ureteral stenosis was defined as a narrowing that precluded the passage of the ureterorenoscope and where no tumoral lesion was detected at the orifice site.
resultsA total of 96 patients were included in the study. A D-J stent was inserted in 49 (51%) of the patients following TUR-BT. At a median follow-up of 30 months, metachronous upper urinary tract urothelial carcinoma developed in 8 (8.3%) patients and ureteral stenosis in 11 (11.5%) patients. Ureteral stenosis developed in 2 (4.1%) patients who underwent D-J stent placement versus 9 (19.1%) patients who did not, a difference that was significant. Age, tumor diameter, presence of carcinoma in situ (CIS), and bladder tumor progression rate were significantly higher in patients with ureteral stenosis. In multivariate logistic regression analysis, only the presence of CIS was identified as an independent predictor of ureteral stenosis.
conclusionAlthough the rate of ureteral stenosis was significantly lower in patients who underwent ureteral stenting, only the presence of CIS was identified as an independent predictor of ureteral stenosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.